Literature DB >> 8010568

Can preoperative and postoperative CEA predict survival after colon cancer resection?

K Slentz1, A Senagore, J Hibbert, W P Mazier, T M Talbott.   

Abstract

Although elevated preoperative carcinoembryonic antigen (CEA) levels are associated with a poor prognosis, little has been written regarding the correlation of CEA response following curative resection of colorectal cancer and its relationship to survival. The purpose of this study, therefore, was to retrospectively evaluate survival in three groups of patients undergoing curative resection (Dukes B and C) for colorectal carcinoma: 1) elevated preoperative CEA/elevated postoperative CEA (EL/EL); 2) elevated preoperative CEA/normal postoperative CEA (EL/NL); and 3) normal preoperative CEA/normal postoperative CEA (NL/NL). A normal CEA was defined as a value < 5.0 ng/mL. Levels were drawn the day before surgery and between 2 and 4 weeks postoperatively. Patients were evaluated for age, sex, histologic grade, CEA levels (pre and postoperative), nerve and venous invasion, tumor site, and survival. There were no significant differences with respect to age, sex, Dukes stage, tumor site, histologic grade, or incidence of nerve or vascular invasion among the three groups. Five-year survival was significantly worse for patients with elevated preoperative CEA levels compared to those with normal preoperative CEA (53% versus 64%, P < 0.05), and for the EL/EL group compared with either of the other two groups (EL/EL: 66.6 +/- 11.8; EL/NL: 87.7 +/- 10.2; Group 3: 93.4 +/- 9.5, P < 0.05 ANOVA). The results indicate that a preoperative elevated CEA, particularly one that fails to decrease to normal postoperatively following a curative resection for colorectal carcinoma, represents a poor prognostic factor. Use of the CEA response may be useful for identifying a subgroup of colorectal cancer patients who are candidates for adjuvant chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8010568

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  25 in total

1.  Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma.

Authors:  Wei-Shu Wang; Jen-Kou Lin; Tzu-Chen Lin; Tzeon-Jye Chiou; Jin-Hwang Liu; Chueh-Chuan Yen; Po-Min Chen
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

2.  Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer.

Authors:  Jung Wook Huh; Seong Hyeon Yun; Seok Hyung Kim; Yoon Ah Park; Yong Beom Cho; Hee Cheol Kim; Woo Yong Lee; Hee Chul Park; Doo Ho Choi; Joon Oh Park; Young Suk Park; Ho-Kyung Chun
Journal:  J Gastrointest Surg       Date:  2018-05-29       Impact factor: 3.452

3.  Incorporation of serum carcinoembryonic antigen levels into the prognostic grouping system of colon cancer.

Authors:  Heita Ozawa; Kenjiro Kotake; Miki Hosaka; Akira Hirata; Yusuke Nakagawa; Shin Fujita; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2017-02-09       Impact factor: 2.571

Review 4.  Rectal cancer: An evidence-based update for primary care providers.

Authors:  Wolfgang B Gaertner; Mary R Kwaan; Robert D Madoff; Genevieve B Melton
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

5.  Rectal adenocarcinoma: proposal for a model based on pretreatment prognostic factors.

Authors:  Fernando Cabanillas; Mariely Nieves-Plaza; Gerardo Quevedo; Ignacio A Echenique
Journal:  P R Health Sci J       Date:  2012-06       Impact factor: 0.705

6.  Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.

Authors:  Mi Joo Chung; Taek Keun Nam; Jae Uk Jeong; Sung Hwan Kim; Kyubo Kim; Hong Seok Jang; Bae Kwon Jeong; Jong Hoon Lee
Journal:  Int J Colorectal Dis       Date:  2016-07-28       Impact factor: 2.571

7.  Monitoring carcinoembryonic antigen in colorectal cancer: is it still useful?

Authors:  G Li Destri; S Greco; C Rinzivillo; A Racalbuto; R Curreri; A Di Cataldo
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

Review 8.  From the genome to the proteome--biomarkers in colorectal cancer.

Authors:  Jens K Habermann; Franz G Bader; Christian Franke; Kaja Zimmermann; Timo Gemoll; Britta Fritzsche; Thomas Ried; Gert Auer; Hans-Peter Bruch; Uwe J Roblick
Journal:  Langenbecks Arch Surg       Date:  2007-10-16       Impact factor: 3.445

9.  Persistent high postoperative carcinoembryonic antigen in colorectal cancer patients--is it important?

Authors:  Ali Ilker Filiz; Ilker Sucullu; Yavuz Kurt; Dursun Ozgur Karakas; Bulent Gulec; Mehmet Levhi Akin
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

10.  Prognostic value of postoperative CEA clearance in rectal cancer patients with high preoperative CEA levels.

Authors:  Jeong Yeon Kim; Nam Kyu Kim; Seung Kook Sohn; Yong Wan Kim; Kim Jin Soo Kim; Hyuk Hur; Byung Soh Min; Chang Hwan Cho
Journal:  Ann Surg Oncol       Date:  2009-08-06       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.